Detalhe da pesquisa
1.
Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma.
Br J Cancer
; 122(12): 1760-1768, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32350413
2.
Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer.
Gut
; 67(3): 497-507, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28077438
3.
Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo.
Br J Cancer
; 111(2): 318-25, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24874484
4.
Cross-sectional survey of daily junk food consumption, irregular eating, mental and physical health and parenting style of British secondary school children.
Child Care Health Dev
; 40(4): 481-91, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23594136
5.
Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells.
Br J Cancer
; 107(10): 1692-701, 2012 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23037716
6.
Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes.
Ann Oncol
; 28(7): 1678-1679, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28430855
7.
How many cisplatin administration protocols does your department use?
Eur J Cancer Care (Engl)
; 19(1): 80-90, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19708939
8.
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer.
Ann Oncol
; 19(7): 1340-1346, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18325912
9.
ABCB1 genetic polymorphism influences the pharmacology of the new pyrrolobenzodiazepine derivative SJG-136.
Pharmacogenomics J
; 8(4): 289-96, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17563765
10.
Short hairpin RNAs targeting Bcl-xL modulate senescence and apoptosis following SN-38 and irinotecan exposure in a colon cancer model.
Cancer Chemother Pharmacol
; 60(5): 651-60, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17273826
11.
Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds.
Biochem Pharmacol
; 71(4): 408-15, 2006 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-16360645
12.
Suramin, an active drug for prostate cancer: interim observations in a phase I trial.
J Natl Cancer Inst
; 85(8): 611-21, 1993 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-8468719
13.
Use of adaptive control with feedback to individualize suramin dosing.
Cancer Res
; 52(1): 64-70, 1992 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-1727387
14.
Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer.
Cancer Res
; 59(12): 2806-9, 1999 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-10383136
15.
Impact of cyclophosphamide on relationships between carboplatin exposure and response or toxicity when used in the treatment of advanced ovarian cancer.
J Clin Oncol
; 11(6): 1156-64, 1993 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-8501502
16.
Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer.
J Clin Oncol
; 12(1): 166-75, 1994 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-8270974
17.
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial.
J Clin Oncol
; 12(9): 1771-7, 1994 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-8083699
18.
Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.
J Clin Oncol
; 10(4): 520-8, 1992 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-1548516
19.
Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer.
J Clin Oncol
; 13(9): 2174-86, 1995 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-7666076
20.
Influence of P-glycoprotein expression on in vitro cytotoxicity and in vivo antitumour activity of the novel pyrrolobenzodiazepine dimer SJG-136.
Eur J Cancer
; 41(12): 1811-8, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16046116